Spronck, E. A., Brouwers, C. C., Vallès, A., de Haan, M., Petry, H., van Deventer, S. J., . . . Evers, M. M. (2019). AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models. Mol Ther Methods Clin Dev.
Styl ChicagoSpronck, Elisabeth A., Cynthia C. Brouwers, Astrid Vallès, Martin de Haan, Harald Petry, Sander J. van Deventer, Pavlina Konstantinova, a Melvin M. Evers. "AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models." Mol Ther Methods Clin Dev 2019.
Citace podle MLASpronck, Elisabeth A., et al. "AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models." Mol Ther Methods Clin Dev 2019.